Neurodegenerative Disease Management (NDM)

Neurodegenerative Disease Management presents findings, analysis and commentary in the ongoing battle with this range of debilitating illnesses. The journal provides guidance to the multidisciplinary disease management community regarding the most effective treatment strategies and the implications of cutting-edge research as it emerges. Topics covered include: All neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s, ALS and multiple sclerosis Disease mechanisms Epidemiology Genetic and environmental influences on disease pathogenesis Clinical manifestations and diagnosis of disease Use of biomarkers in diagnosis and prognosis Use of technology to track symptoms and impact of treatment Therapeutic options Evaluation and management of cognitive impairment and dementia Prospects for new treatments such as cell and gene therapy Medical treatment guidelines Adverse events and drug safety Pharmacoeconomics, outcomes research, real-world evidence and quality of life Disease management in developed and developing countries Palliative care

Neurodegenerative Disease Management (NDM) is :-

• International, Peer-Reviewed, Open Access, Refereed, Disease mechanisms, Epidemiology, Therapeutic options, Adverse events and drug safety, Pharmacoeconomics, outcomes research, real-world evidence, quality of life, impact of treatment, Use of biomarkers in diagnosis , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1758-2024, E-ISSN: 1758-2032, Established: 2011, Impact Factor: 2.3
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE